Skip to content

Author

S. Kemp

We have 2 of 33 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy

These findings demonstrate DTG resistance in both adult and paediatric participants with virological failure with G118R emerging as a prominent resistance pathway and support continued surveillance of integrase and capsid resistance as long-acting antiretroviral strategies expand.

A. Abdullahi, S. Osawe, H. Wisso et al. · 0 citations
Jul 2026

Complex intra-host SARS-CoV-2 evolution following monoclonal antibody pre-exposure prophylaxis 2309595

Fixation of E340D abolished the surrogate defence provided by sotrovimab, eliminating neutralizing activity and exerting a positive epistatic effect on emerging mutations, which conferred the highest infectivity across all cell lines, with the most significant effect in low-TMPRSS2 cells.

K. Kamelian, D. Pascall, M. Cheng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.